MYDA Advisors’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

MYDA Advisors’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-728,800	Closed	-$7.3M	–	182
2022 Q3	$7.3M	Sell	728,800 -171,200	-19%	-$1.7M	3.43%	4
2022 Q2	$8.9M	Sell	900,000 -70,000	-7%	-$691K	2.49%	5
2022 Q1	$9.56M	Sell	970,000 -12,000	-1%	-$118K	3.78%	1
2021 Q4	$9.62M	Hold	982,000	–	–	2.57%	3
2021 Q3	$9.63M	Hold	982,000	–	–	2.7%	3
2021 Q2	$9.71M	Buy	982,000 +2,000	+0.2%	+$20.1K	2.42%	4
2021 Q1	$10.1M	Buy	+980,000	New	+$10.9M	2.79%	1

MYDA Advisors's LUXA Position: Q4 2022 in Review

MYDA Advisors sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 728,800 shares — an estimated $7.3M sold.

MYDA Advisors first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $10.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

MYDA Advisors reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
MYDA Advisors sold 728,800 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $7.3M.
MYDA Advisors first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
MYDA Advisors's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $10.1M in Q1 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on MYDA Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.